文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

The Effects of Hemodialysis and Peritoneal Dialysis on the Gut Microbiota of End-Stage Renal Disease Patients, and the Relationship Between Gut Microbiota and Patient Prognoses.

作者信息

Luo Dan, Zhao Wenbo, Lin Zhiming, Wu Jianhao, Lin Hongchun, Li Yongjie, Song Jun, Zhang Jun, Peng Hui

机构信息

Department of Nephrology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

Department of Nephrology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

出版信息

Front Cell Infect Microbiol. 2021 Mar 23;11:579386. doi: 10.3389/fcimb.2021.579386. eCollection 2021.


DOI:10.3389/fcimb.2021.579386
PMID:33834002
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8021868/
Abstract

Gut microbiota alterations occur in end-stage renal disease (ESRD) patients with or without dialysis. However, it remains unclear whether changes in gut microbiota of dialysis ESRD patients result from dialysis or ESRD, or both. Similarly, there is a dearth of information on the relationship between gut microbiota and ESRD prognoses. We collected fecal samples and tracked clinical outcomes from 73 ESRD patients, including 33 pre-dialysis ESRD patients, 19 peritoneal dialysis (PD) patients, and 21 hemodialysis (HD) patients. 16S rRNA sequencing and bioinformatics tools were used to analyze the gut microbiota of ESRD patients and healthy controls. Gut microbiota diversity was different before and after dialysis. Bacteroidetes were significantly deceased in HD patients. Twelve bacterial genera exhibited statistically significant differences, due to dialysis (all < 0.05, FDR corrected). HD reversed abnormal changes in and in pre-dialysis patients. Functional predictions of microbial communities showed that PD and HD altered signal transduction and metabolic pathways in ESRD patients. Furthermore, and were associated with cardiovascular mortality. , , and were related to peritonitis in PD patients. This study not only demonstrated differences in gut microbiota between pre-dialysis and dialysis ESRD patients, but also firstly proposed gut bacteria may exert an impact on patient prognosis.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bef/8021868/bdec29770cc0/fcimb-11-579386-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bef/8021868/bbfe87d71013/fcimb-11-579386-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bef/8021868/5a962e6c26bf/fcimb-11-579386-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bef/8021868/4f0dc14b8568/fcimb-11-579386-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bef/8021868/0c1fb9ca5a6e/fcimb-11-579386-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bef/8021868/c9903d0c5ee2/fcimb-11-579386-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bef/8021868/bdec29770cc0/fcimb-11-579386-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bef/8021868/bbfe87d71013/fcimb-11-579386-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bef/8021868/5a962e6c26bf/fcimb-11-579386-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bef/8021868/4f0dc14b8568/fcimb-11-579386-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bef/8021868/0c1fb9ca5a6e/fcimb-11-579386-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bef/8021868/c9903d0c5ee2/fcimb-11-579386-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bef/8021868/bdec29770cc0/fcimb-11-579386-g006.jpg

相似文献

[1]
The Effects of Hemodialysis and Peritoneal Dialysis on the Gut Microbiota of End-Stage Renal Disease Patients, and the Relationship Between Gut Microbiota and Patient Prognoses.

Front Cell Infect Microbiol. 2021-3-23

[2]
Exploration of the correlation between intestinal flora and peritoneal dialysis-related peritonitis.

Clin Exp Nephrol. 2022-10

[3]
Peritoneal dialysis promotes microbial-driven biosynthesis pathways of sesquiterpenes and triterpenes compounds in end-stage renal disease patients.

BMC Microbiol. 2024-9-28

[4]
Exploration of the correlation between intestinal flora and Escherichia coli peritoneal dialysis-related peritonitis.

BMC Nephrol. 2022-2-22

[5]
Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium study.

Microbiome. 2016-9-17

[6]
Correlation between intestinal flora disruption and protein-energy wasting in patients with end-stage renal disease.

BMC Nephrol. 2022-4-4

[7]
High-throughput sequencing analysis of intestinal flora changes in ESRD and CKD patients.

BMC Nephrol. 2020-1-13

[8]
Altered gut microbiota and gut-derived p-cresyl sulfate serum levels in peritoneal dialysis patients.

Front Cell Infect Microbiol. 2022

[9]
Advanced glycation end products dietary restriction effects on bacterial gut microbiota in peritoneal dialysis patients; a randomized open label controlled trial.

PLoS One. 2017-9-20

[10]
Correlation between gut microbiome and cognitive impairment in patients undergoing peritoneal dialysis.

BMC Nephrol. 2023-12-5

引用本文的文献

[1]
Gut microbiome remodeling in chronic kidney disease: implications of kidney replacement therapies and therapeutic interventions.

Front Med (Lausanne). 2025-7-15

[2]
Molecular frontiers in hemodialysis: unraveling the role of membranes in gene expression, epigenetics, and inflammatory pathways.

Int Urol Nephrol. 2025-6-25

[3]
Immune-microbiota dysregulation in maintenance hemodialysis: a 16S rRNA sequencing-based analysis of gut flora and T cell profiles.

Ren Fail. 2025-12

[4]
Gut microbiome dynamics of patients on dialysis: implications for complications and treatment.

Front Pharmacol. 2025-4-25

[5]
The role of the intestinal microbiome in cognitive decline in patients with kidney disease.

Nephrol Dial Transplant. 2025-3-13

[6]
Decrease in Escherichia-Shigella in the gut microbiota of ESKD patients undergoing maintenance hemodialysis.

BMC Nephrol. 2025-2-25

[7]
Targeted modulation of intestinal barrier and mucosal immune-related microbiota attenuates IgA nephropathy progression.

Gut Microbes. 2025-12

[8]
Gut microbiota and their metabolites in hemodialysis patients.

Chin Med J (Engl). 2025-2-20

[9]
Probiotic interventions in peritoneal dialysis: A review of underlying mechanisms and therapeutic potentials.

World J Nephrol. 2024-12-25

[10]
Dyslipidemia in Peritoneal Dialysis: Implications for Peritoneal Membrane Function and Patient Outcomes.

Biomedicines. 2024-10-17

本文引用的文献

[1]
A Pilot Study on the Effect of Prebiotic on Host-Microbial Co-metabolism in Peritoneal Dialysis Patients.

Kidney Int Rep. 2020-6-1

[2]
Characterizing the gut microbiota in patients with chronic kidney disease.

Postgrad Med. 2020-4-2

[3]
Serum lipoprotein(a) and risk of mortality in patients on peritoneal dialysis.

J Clin Lipidol. 2020

[4]
Interleukin-22-mediated host glycosylation prevents Clostridioides difficile infection by modulating the metabolic activity of the gut microbiota.

Nat Med. 2020-2-17

[5]
Peritoneal Microbiome in End-Stage Renal Disease Patients and the Impact of Peritoneal Dialysis Therapy.

Microorganisms. 2020-1-25

[6]
Using MicrobiomeAnalyst for comprehensive statistical, functional, and meta-analysis of microbiome data.

Nat Protoc. 2020-1-15

[7]
High-throughput sequencing analysis of intestinal flora changes in ESRD and CKD patients.

BMC Nephrol. 2020-1-13

[8]
The gut microbiota-inflammation-brain axis in end-stage renal disease: perspectives from default mode network.

Theranostics. 2019-10-18

[9]
Intestinal microbiome and fitness in kidney disease.

Nat Rev Nephrol. 2019-6-26

[10]
Gut microbiota profile in children affected by atopic dermatitis and evaluation of intestinal persistence of a probiotic mixture.

Sci Rep. 2019-3-21

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索